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Abstract 
Background: Severe early childhood caries (s-ECC), which has quite high prevalence among children, is a wide-
spread problem with significant impacts among both developing and developed countries. At present, it is widely 
known that no early detective techniques and diagnostic tests could have high sensitivity and specificity when using 
for clinical screening of s-ECC. In this study, we had applied magnetic bead (MB)-based matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to screen distinctive candidate biomarkers of this 
disease, so as to establish protein profiles and diagnostic models of s-ECC.
Methods: Firstly, we used the technique mentioned above to detect specifically expressed peptides in saliva sam-
ples from ten children with s-ECC, separately at the time point of before, 1 and 4 weeks after dental treatment. Then 
a diagnostic model for s-ECC was established with the K nearest-neighbour method, which was validated in another 
six children in the next stage of study. After that, linear ion trap-orbitrap-mass spectrometry (LTQ-Orbitrap-MS) was 
performed to identify which of the proteins in saliva might be the origination of these peptides.
Results: We found that seven peptide peaks were significantly different when comparing the three time points, 
among them two were higher, while other five were lower in the pre-treatment s-ECC group compared with post-
treatment. The sensitivity and specificity of the diagnostic model we built were both 83.3 %. Two of these peptides 
were identified to be segments of histatin-1, which was one important secretory protein in saliva.
Conclusions: Hereby we confirmed that MB-based MALDI-TOF MS is an effective method for screening distinc-
tive peptides from the saliva of junior patients with s-ECC, and histatin-1 may probably be one important candidate 
biomarker of this common dental disease. These findings might have bright prospect in future in establishing new 
diagnostic methods for s-ECC.
Keywords: MALDI-TOF MS, Proteomics, Saliva, s-ECC, Biomarker, Histatin-1, Early diagnosis
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Dental caries is one common chronic disease among chil-
dren [1], remaining a major problem in many countries 
[2–5]. Severe early childhood caries (s-ECC) is its aggres-
sive form, defined by one or more of the following criteria: 
(1) any sign of smooth surface caries in children aged <3; 
(2) one or more decayed, missing (due to caries), or filled 
tooth surfaces in primary maxillary anterior teeth in those 
aged 3–5; (3) having decayed, missing, or filled surface 
score (dmfs) more than four at age 3, or more than five at 
4, or more than six at 5 [6]. s-ECC can reduce the children’s 
ability of eating and drinking, resulting in tooth decay or 
malocclusion of permanent dentition [7, 8]. These further 
cause malnutrition, speaking and sleeping problems, as 
well as impair the school performance, social behaviour, 
and self-esteem of the patients [4]. Therefore, s-ECC has 
made many negative impacts on the quality of life of pre-
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Paediatric dental caries is also a significant problem in 
China. According to the national epidemiological report, 
the prevalence of dental caries among 5-year-old children 
reached 66  %, with mean dmfs 3.5 [10]. Recent studies 
demonstrated that polarization of caries has been more 
pronounced [11–13].
The known factors influencing dental caries in children 
includes: (1) immature immune systems; (2) character-
istics of saliva; (3) cariogenic microorganisms; (4) feed-
ing type; (5) oral hygiene care in early childhood [14]. 
Recently, the characteristics and components of saliva 
have also been suggested to forewarn the development of 
s-ECC [15].
Saliva is one important body fluid containing complex 
components which has great diagnostic value [16, 17]. As 
the host-associated factor, saliva plays an essential role 
in dynamic equilibrium between demineralization and 
remineralization, changing the sensitivity and resistance 
to dental caries [18]. Many proteins in saliva function 
during adhesing and aggregating of cariogenic bacteria 
[18–20]. However, some other proteins in saliva may con-
tribute to the defence against microorganisms [21–23].
Recently, new proteomics techniques, including high-
throughput analysis of the salivary proteome, make it 
possible to characterize its protein composition and 
investigate its impact on development of dental caries. 
Matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry (MALDI-TOF MS) is a useful method 
for identification of microbes and proteins, which has 
high efficiency and automation but lower costs [24–26], 
making great benefits to clinical and laboratorial experi-
ments. It is one of the most promising techniques to 
reduce the huge gap between high throughput prot-
eomics and clinical studies with large samples [27, 28]. 
MALDI-TOF MS can be used in combination with weak 
cation-exchanger (WCX) magnetic bead to select pep-
tides from saliva in the range of 1000–10,000  Da prior 
to further identification. The WCX magnetic beads can 
separate the proteins and/or peptides of different iso-
electric points from complex biological fluids with spe-
cific anionic ligands, which is confirmed to be suitable 
for the fractionation of low-molecular-mass range pep-
tides (1–10,000 Da) and can exhibit optimal performance 
which can be confirmed in many studies, such as some 
cancer research [29, 30]. The techniques of MALDI-TOF 
MS combined with WCX magnetic beads incorporate 
both of their advantages such as low cost and simple 
purification, which could capture more peptides than 
some other methods especially in the low-molecular-
mass range [31, 32].
In the previous study from our research group, we have 
designed a cross-sectional study to introduce weak cat-
ion-exchanger magnetic bead-based matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry 
(WCX MB-based MALDI-TOF MS) to compare the com-
ponents of salivary peptides in children with and with-
out s-ECC, and successively found certain differentially 
expressed peptides between caries and non-caries children 
[33]. Based on the former research, in the present study 
we also use this method, WCX MB-based MALDI-TOF 
MS, to evaluate the profiles of salivary peptides in those 
children with s-ECC at different time points of before, 1 
and 4 weeks after treatment, so as to verify the hypothesis 
that certain peptides in saliva are associated with differ-
ent periods of before and after treatment of dental caries 
in children, and could be used as candidate biomarkers for 
diagnosis and identification of status of s-ECC.
Methods
Ethics statement
This study was ethically approved by Institutional 
Review Board of Peking University School of Stomatol-
ogy (PKUSSIRB-2013060). The parents of children who 
attended this study have all signed informed consent.
Sampling
The sampling for this study was performed at the kinder-
garten affiliated to Renmin University of China (Beijing, 
China) in late 2013. Only children with the following 
conditions were included: (1) 3–5  years old, clinically 
diagnosed with s-ECC; (2) no influenza or infection 
of respiratory system, and received neither antibiotic 
therapy within 1 month nor fluoride prophylaxis within 
1 year; (3) no medical history of congenital diseases; (4) 
able to spit the saliva and comply with dental treatment; 
(5) informed consent signed by the parents. 16 children 
reaching these criteria were included in the study.
Collection and processing of saliva samples
After breakfast, all these children rinsed their mouth 
with clean water, then their stimulated whole-saliva sam-
ples were collected. After centrifugation at 10,000×g 
for 10  min at 4  °C, the supernatant was obtained, and 
1  mM ethylene diamine tetraacetic acid (Sigma, St. 
Louis, MO) together with 1  mM phenylmethylsulfonyl-
fluoride (Sigma) were added to inhibit protease activity. 
Protein concentration was measured by Lowry method 
and ELx808 Protein Assay (BioTek, Hercules, CA). Then 
these supernatants were stored at −80 °C.
Pretreatment of MBs
A weak cation exchange magnetic bead (WCX MB) kit 
from Bioyong Tech (Beijing, China) was used. Alpha-
cyano-4-hydroxycinnamic acid (CHCA) was dissolved 
freshly in 100  % ethanol (chromatographic grade) and 
100  % acetone (chromatographic grade) to prepare the 
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sample matrix for MALDI-TOF MS (Bruker Bio-sci-
ences, Bremen, Germany).
All saliva samples were fractionated using WCX MBs 
(Bioyong Tech, Beijing, China). Samples were purified 
and isolated with the following steps: (1) 20 μL of beads, 
150  μL of MB-WCX binding solution (CB), and 20  μL 
of salivary sample were mixed carefully and incubated 
for 5 min. (2) The tubes were placed on the MB separa-
tion device (Bioyong Tech) and the beads were allowed 
to collect on the tube wall for 1 min. (3) The supernatant 
was removed by washing and mixed thoroughly with 
180 μL of MB washing solution (CW). (4) Another 10 μL 
of MB elution solution (CE) was added, and the beads 
were allowed to gather on the tube wall in the separation 
device for 2  min. (5) Clear supernatant was transferred 
into a fresh tube, and the peptides were analysed directly 
on a ClinTOF instrument (Bioyong Tech) or stored at 
−20 °C.
Anchor chip spotting and MALDI‑TOF MS profiling
The matrix solution, 5  mg/mL CHCA in 50  % ace-
tone/0.1  % TFA solution (α-cyano-4-hydroxycinnamic 
acid) was prepared. First, 1 µL of purified peptide solu-
tion was spotted onto a MALDI-TOF MS target by 
ClinTOF (Bioyong Tech). After drying at room tempera-
ture, 1 µL of matrix solution was spotted onto the sam-
ple, and dried again before analysis. MALDI-TOF MS 
measurements were performed using a ClinTOF instru-
ment (Bioyong Tech).
Before analysing, a three-peptide mixture (monoiso-
topic molecular weights of 1532.8582, 2464.1989, and 
5729.6087  Da, Product Numbers P2613, A8346, and 
I6279, respectively; Sigma) was used for calibration of the 
MALDI-TOF MS. Profile spectra were acquired from an 
average of 400 laser shots per sample. The mass range of 
1000–10,000 Da was collected. Each sample of saliva was 
analysed for 3 times, and the mean value of each sample 
was used for the analysis.
Data processing
We chose ten children randomly from the full sample for 
analysis of salivary peptide profiles in each group (s-ECC 
before treatment, 1 and 4 weeks after treatment), and in 
total 30 salivary samples were analysed. The reproduc-
ibility of the mass spectra was determined from the mean 
relative peak intensities. All of the spectra obtained from 
the saliva samples in the training set were analysed using 
BioExplorer (Bioyong Tech) to subtract the baseline, 
normalize spectra (using total ion current), and deter-
mine peak m/z values and intensities in the mass range 
1000–10,000 Da. A signal-to-noise ratio >5 was required. 
To align the spectra, a mass shift of no more than 0.1 % 
was determined. The peak area was used for quantitative 
standardization. The KNN in this software suite was 
used to establish the best pattern of diagnostic model for 
identifying s-ECC. Validation of the diagnostic model 
was carried out in a new series of the other six children 
with s-ECC, at the time points of before and after treat-
ment for 1 and 4 weeks, and both sensitivity and speci-
ficity of this model were calculated. In this section, after 
each profile generated, 20  % leave-out cross-validation 
was performed in the software. Comparison of relative 
peak intensity levels between classes was also performed, 
and P <0.01 was considered as threshold of statistical 
significance.
Identification of candidate peptide biomarkers 
by nano‑LC/ESI–MS/MS
Peptide sequences
The sequences of diagnostic peptides in the model were 
identified using a nano-liquid chromatography-electro-
spray ionization-tandem mass spectrometry (nano-LC/
ESI–MS/MS) system consisting of an ACQUITY UPLC 
system (Waters, Milford, MA) and an LTQ Obitrap XL 
mass spectrometer (Thermo Fisher Scientific, Rock-
ford, IL) equipped with a nano-ESI source. The MS/MS 
experimental protocol was as follows: The peptide solu-
tions were loaded onto a C18 trap column (Symmetry 
nanoACQUITY; Waters) (180  μm  ×  20  mm  ×  5  μm) 
with a flow rate of 15 μL/min. Then, the desalted pep-
tides were enriched on a C18 analytical column (Sym-
metry nanoACQUITY) (75  μm  ×  150  mm  ×  3.5  μm) 
at a flow rate of 400  μL/min. Third, the mobile phases 
A (5 % acetonitrile and 0.1 % formic acid) and B (95 % 
acetonitrile and 0.1  % formic acid) were used on the 
analytical columns. Peptides were eluted using solvent 
B with the gradient elution profile 5 % B—50 % B—80 % 
B—80 % B—5 % B—5 % B in 100 min. The MS instru-
ment was operated in data-dependent mode. The range 
of the full scan was 400–2000 m/z with a mass resolu-
tion of 100,000 (m/z 400). The eight monoisotope ions 
with the highest intensities were the precursors for 
collision-induced dissociation. MS/MS spectra were 
limited to two consecutive scans per precursor ion 
followed by 60  s of dynamic exclusion. Acetylization 
(N-Term) and oxidation (M) were used as post-transla-
tional modifications.
Bioinformatics and identification of candidate saliva 
biomarkers
The chromatograms were analysed with Bioworks 
Browser 3.3.1 SP1 and the resulting mass lists were used 
for database searches using Sequest™ (IPI Human 3.45). 
The parameters for generating the peak list were as fol-
lows: parent ion, 50  μg/g; fragment mass relative accu-
racy, 1 Da.
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Western blotting analysis
Salivary protein concentration was measured by bicin-
choninic acid (BCA) kit (Solarbio, China). Salivary total 
protein (20  μg) underwent electrophoresis in 18  % gels 
for sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS–PAGE) using Mini-PROTEAN Tetra 
Cell System (Bio-Rad, USA). Proteins were then trans-
ferred to polyvinylidene fluoride (PVDF) membranes. 
The total protein load was checked visually by Ponceau 
staining before immuno-detection. The membranes 
were blocked overnight at 4 °C with 10 % skimmed milk 
in Tris-buffered saline (TBS, pH 7.4), followed by wash-
ing with TBS buffer containing 0.05 % tween20 (TBST). 
Membranes were incubated with the primary antibody 
specific for histatin-1 protein (ab70024, Abcam, UK) and 
anti-GAPDH (glyceraldehyde-3-phosphate dehydroge-
nase) monoclonal antibody (TA-08, ZSGB-Bio, China) at 
room temperature for 1 h. And the secondary antibodies 
used were rabbit polyclonal anti mouse immuno-globin 
G-horseradish peroxidase (IgG-HRP) (ab97046, Abcam) 
with the same condition, then the excess ones were 
removed. After that, the immuno-reactive bands were 
visualized by Odyssey scanner (Gene Company Limited, 
Hong Kong), and western blotting bands were quantified 
using Image J software (http://www.rsbweb.nih.gov/ij/).
Statistical analysis
Data were analysed with the BioExplorer statistical pack-
age (Bioyong Tech). Depending on the results of normal-
ity tests, analysis of variance (ANOVA) or Kruskal–Wallis 
test was chosen to analyse statistical differences in pep-
tide levels among saliva samples. The western blotting 
data was analysed with two-tailed paired t test. In all 
analyses, P < 0.01 was identified as statistical significance.
Results
Study population
In total 16 children with an average age of 4.7 ± 0.5 years 
(11 males and 5 females) received oral examination, and 
were sampled for saliva before and after 1 and 4 weeks of 
treatment. Information of these participants were shown 
in Additional Table 1 (Additional file 1).
Peptide profiles
30 stimulated whole saliva samples were collected 
from 10 children (randomly selected from the whole 
sample) with s-ECC before and after 1 and 4  weeks 
of treatment. The entire mass spectra of the peptides 
from these samples were analysed and compared by 
MALDI-TOF MS (Fig. 1). Saliva peptidome fingerprint 
peaks from each patient were quantified based on the 
maximum intensity within a particular m/z range. The 
majority of the peptides had molecular weights in the 
range 1000–7000 Da.
Eighty one peptide mass peaks were simultaneously 
detected in all the 3 groups as shown in Additional Table 2 
(Additional file 1). The peak intensities differed significantly 
for 7 peptides (experimental m/z values: 1370.4, 1723.7, 
1851.4, 1886.5, 2331, 2995.7, and 3310.0  Da; Figs.  2, 3a), 
which abundance values were shown in Additional Table 3 
(Additional file 1). Two peptides (experimental m/z values: 
1370.4 and 3310.0  Da) were higher in the s-ECC children 
before treatment, whereas other 5 peptides (experimental 
m/z values: 1723.7, 1851.4, 1886.5, 2331.0, and 2995.7 Da) 
got higher peaks in the groups treated for 1 and 4 weeks. 
Two peptides (experimental m/z values: 1723.7 and 
2995.7  Da) exhibited the most significant difference 
(P  <  0.01) when comparing these groups, while the fit-
ted results of the other combinations were less good. In 
addition, these 2 peptides were downregulated in the 
untreated group (Figs. 2, 3a). The level of the peptide with 
experimental m/z values of 1723.7 Da was lower in each 
of the untreated children compared with after treatment 
for 1 and 4 weeks (Fig. 3b). Therefore, we chose these two 
peptides to establish a fitted curve for they could show 
the best distinction (Fig. 3c). The shape showed that the 
samples from the 3 groups were well-separated, indicat-
ing that the fitting results were satisfactory.
Four of the seven mass peaks (experimental m/z val-
ues: 1723.7, 1851.4, 2331.0, and 2995.7  Da) were used 
to establish a diagnostic model by the KNN method. In 
validation stage, five of the six s-ECC patients (sensitiv-
ity 83.3 %) were clinically diagnosed as s-ECC, and five of 
those treated for 1 and 4 weeks (specificity 83.3 %) were 
correctly grouped by this diagnostic model (Fig. 3c).
Moreover, with LTQ-Orbitrap-MS detection, four of 
the seven differentially expressed peptides (experimental 
m/z values: 1723.7, 1851.4, 1886.5, and 2331.0 Da) were 
successfully identified (Table 1). The peptides with exper-
imental m/z values of 1723.7 and 1886.5  Da were pre-
dicted to be segments of histatin-1, which are considered 
to be one major factor of the protective proteinaceous 
structure on the tooth surface (enamel pellicle), exhibit-
ing antibacterial and antifungal activity [18, 34].
Western blotting results
Sixteen stimulated whole saliva samples were collected 
from eight children with s-ECC (randomly chosen from 
the whole sample) before and after 4 weeks of treatment. 
The density of histatin-1 was divided by that of GAPDH 
for each sample to normalize the level of histatin-1. The 
levels of salivary histatin-1 were higher in children with 
s-ECC after treatment for 4 weeks compared with before 
treatment (P < 0.01) (Fig. 4).
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Discussion
Paediatric dental caries is a major public health problem, 
becoming the most common chronic infectious disease 
in childhood of great concern to parents and dentists [4, 
6]. Saliva and its components play important roles in pro-
tecting oral structures. Although infection of Streptococ-
cus mutans, inappropriate feeding and diet, and poor oral 
hygiene care are all causal factors, but endogenous fac-
tors, such as characteristics of saliva, may determine why 
some children develop caries while others do not [15, 35, 
36].
In this study, we used proteomic technique to detect 
and discriminate peptide profiles in stimulated whole 
saliva from children aged 3–5  years with s-ECC com-
pared with after 1 and 4  weeks of treatment. Conven-
tional salivary proteomics studies mainly used 2-DE and 
SDS-PAGE, in which proteins are separated in terms of 
their molecular weight, followed by MS for identification. 
However, these strategies have several significant disad-
vantages, including complex procedures, the large sam-
ple size required, and that the informative low molecular 
weight peptides are likely outside their detection range 
[37].
Currently, the contribution of the different sources to 
whole saliva, and the evaluation of individual variability 
and physiological modifications have been investigated 
by top–down proteomic approaches, disclosing the fac-
eted and complex profile of the human salivary proteome 
[38]. In a study, the whole saliva of 88 children aged 
between 0 and 48 months were analysed by a top–down 
platform based on RP-HPLC–ESI–MS, the result showed 
how the salivary proteome of human children evolves 
during infant development and concentrations of some 
salivary proteins (acidic proline-rich proteins, histatin-1, 
histatin-3, statherin, P-B peptide, and salivary cystatins) 
slowly increased with age, with different trends [39]. Top-
down proteomic approaches were also used to detect bio-
markers in some systemic diseases, such as schizophrenic 
and bipolar disorder [40], lung cancer [41], and chronic 
graft-versus-host disease [42].
In our study, we are using MB-based MALDI-TOF MS, 
which is an approach that overcomes some limitations of 
conventional salivary proteomics. MBs are micro-parti-
cles available with a range of different surface chemistries 
providing a choice of functionalities [43]. They are used 
for sample preparation (e.g., saliva, serum, plasma, urine, 
and cerebrospinal fluid) to enrich target low molecular 
weight and low-concentration peptides by their specific 
affinities [31]. In comparison with other time-consuming 
techniques in proteomics, the MB-based MALDI-TOF 
MS technique is rapid, high-throughput, and precise, 
with adequate resolution and sensitivity for the investi-
gation of complex salivary samples [32]. It has also been 
used to detect and identify specific candidate biomarkers, 
not only in oral pathologies, such as periodontitis [44] 
and oral cancer [45], but also in systemic diseases, such 
as Sjögren’s syndrome [46], rheumatoid arthritis [47], and 
systemic lupus erythematosus [30].
In our results, the intensities of seven peaks (Figs.  2, 
3a) differed significantly between the pre- and post-
treatment s-ECC groups, indicating that this method can 
be used to analyse the peptide profiles in children with 
dental caries. We also found that several peptides were 
associated with having experienced caries, and might 
influence the onset and development of early childhood 
caries. We verified the diagnostic model established 
using four peptides (experimental m/z values: 1723.7, 
1851.4, 2331.0, and 2995.7 Da) in other six cases and the 
results showed sensitivity and specificity of this model 
were both 83.3  %, indicating these salivary peptides 
should be potential candidate biomarkers of s-ECC. In 
Fig. 1 The entire mass spectra of the peptide samples in the range 
1000–10,000 Da. These data were from ten patients with s-ECC before 
and after treatment. Green, untreated; red, treated for 1 week; blue, 
treated for 4 weeks. m/z, mass-to-charge ratio
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the previous study by Si et al. [33], the findings revealed 
different composition of significantly expressed peptides 
between children with and without dental caries under 
a cross-sectional study design. The samples were from 
children in a different kindergarten, and dental caries in 
that study were not treated before analysis. Our present 
study was a longitudinal study with caries treatment, 
which was an entirely different design and could better 
obtain the potential biomarkers of caries treatment and 
experience. However, further studies are still needed if 
we would like to draw a full picture of diagnosis of den-
tal caries, especially to explore the difference between 
untreated non-caries, untreated caries, well-treated car-
ies and secondary caries.
Some previous studies have identified salivary peptides, 
including histatins, defensins, and proline-rich proteins 
(PRPs), may contribute to paediatric caries [18, 48, 49]. In 
this study, two peptides (experimental m/z values: 1723.7 
and 1886.5 Da) were predicted to be segments of hista-
tin-1 (Table 1), and their levels of expression were lower 
in the pre-treatment than post-treatment s-ECC group. 
However, the difference between their sequences were 
only one amino acid (tyrosine), indicating these two pep-
tides might be homogenous. But on the other hand, this 
will provide much stronger evidence for histatin-1 as a 
candidate biomarker for dental caries.
Histatins are salivary proteins that have a high affin-
ity for hydroxyapatite and contribute to the acquired 
Fig. 2 Three-dimensional m/z ratio-intensity maps. Those showed the seven significantly different peptides at 1723.7, 1851.4, 1886.5, 2331, 2995.7, 
1370.4, and 3310.0 Da. Green, untreated; red, treated for 1 week; blue, treated for 4 weeks
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Fig. 3 Histograms and scatter plots from the three groups. a Histogram of the mass spectra from the three groups, showing increased expression of 
peptides at 1723.7, 1851.4, 1886.5, 2331.0, and 2995.7 Da, and decreased expression of those at 1370.4 and 3310.0 Da, in s-ECC patients treated for 
1 and 4 weeks. (*P < 0.05; **P < 0.01). b Histogram of the mass spectra at 1723.7 Da of all patients from the three groups, showing increased expres-
sion in s-ECC patients treated for 1 and 4 weeks. (*P < 0.05; **P < 0.01). c Scatter plots of the three groups established by combining the peptides at 
1723.7 and 2995.7 Da, and showing well-distinguished curve fitting
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enamel pellicle [50]. When histatins are adsorbed onto 
the enamel surface, they provide protection against acid 
aggression [51]. In this study, we collected 16 stimu-
lated whole saliva samples from 8 children with s-ECC 
before and after 4  weeks of treatment (equal amounts 
of the total protein were used for each sample) who 
were randomly chosen from the whole sample, to per-
form western blotting assay in order to learn the differ-
ence of protein expression of histatin-1 between different 
time points before and after treatment of dental caries. 
Western blotting was performed in parallel with constant 
conditions, and we found that the levels of salivary hista-
tin-1 were higher in children with s-ECC after treatment 
for 4 weeks compared with before treatment (P < 0.01), 
which was consistent with the tendency of expression of 
the two peptides with experimental m/z values of 1723.7 
and 1886.5 during different period of treatment of dental 
caries in MALDI-TOF MS. In a study performed in 2005, 
high-performance liquid chromatography-mass spec-
trometry (HPLC–MS) was used to investigate the corre-
lation between salivary peptides and dental caries in 20 
samples, who were divided by dmfs index into two groups 
[18]. The results indicated strong correlations between 
high levels of phosphopeptides (PRP 1-3, histatin-1, and 
statherin) and the absence of dental caries. Results of the 
present study were consistent with it despite the different 
method applied. These above suggested that histatin-1 
played a significant role in maintaining tooth integrity 
and protection against cariogenic bacteria, and might be 
associated with having experienced caries.
In addition, we found prolactin inducible protein (PIP) 
and myoglobin might also be candidate biomarkers of 
dental caries. PIP is a 17  kDa single polypeptide chain, 
known by various names due to its versatile nature and 
function in human reproductive and immune systems, 
which expressed in lacrimal, salivary, and sweat glands 
[52]. It is considered as a prognostic biomarker because 
of its over-expression in metastatic breast and prostate 
cancer [53, 54]. Moreover, its aspartyl-proteinase nature 
suggests its role in tumour progression [55, 56]. In saliva, 
PIP is a lipopolysaccharide-binding (LPS-binding) pro-
tein capable of binding to many bacteria living in oral 
cavity, including A. actinomycetemcomitans, P. gingi-
valis [57], Gemella haemolysans, Gemella morbillorium, 
Streptococcus acidominimus, Streptococcus oralis, Strep-
tococcus salivarius and Streptococcus parasanguinis 
Table 1 Peptide sequences identified by LTQ-Orbitrap-MS among those differentially expressed in MALDI-TOF MS
Values reported here are the mono-charged ions of the peptides of interest for the study
m/z mass-to-charge ratio
Experimental m/z value Peptide (SwissProt Code) Peptide sequence Theoretical m/z value
1370.4 Unknown peptide
1723.7 sp|P15515| HUMAN histatin-1 REFPFYGDYGSNYL 1726.763
1851.4 sp|P02144| myoglobin GHHEAEIKPLAQSHATK 1852.954
1886.5 sp|P15515| HUMAN histatin-1 REFPFYGDYGSNYLY 1889.826
2331.0 sp|P12273| prolactin-inducible protein AAVIPIKNNRFYTIEILKVE 2330.336
2995.7 Unknown peptide
3310.0 Unknown peptide
Fig. 4 Salivary histatin-1 levels increased in children with s-ECC treated for 4 weeks. These levels were compared with before treatment. a Western 
blotting reveals the presence of histatin-1 in each salivary sample. b The relative density of the histatin-1 bands, revealing that levels of salivary 
histatin-1 are higher in children with s-ECC after treated for 4 weeks compared with before treatment  (**P < 0.01)
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[58]. PIP may play an important role in the blockage of 
bacterial adhesion, contributing to pathogenesis and 
host immunity. We could only find very few related stud-
ies on the relationship between PIP and dental caries in 
recent years. In one study in 2014, magnetic beads and 
LTQ-Orbitrap hybrid Fourier transform mass spectrom-
etry were used to identify the Streptococcus mutans 
lipoteichoic acid (Sm.LTA) binding proteins in the saliva 
of caries-free and caries human subjects. However, the 
results indicated that the expression of prolactin-induc-
ible protein had no significant difference in both groups 
[59]. Meanwhile, myoglobin, one protein that was known 
to bind oxygen in myocardium and skeletal muscles, was 
not reported relevant to saliva and dental caries in previ-
ous studies. Further studies will be needed to explore the 
probable function of PIP and myoglobin in dental caries.
Although proteome profiling using MB-based MALDI-
TOF MS together with LTQ-Orbitrap-MS is effective for 
the identification of saliva-specific peptides, some limita-
tions are still remaining. First, identifying all the peaks was 
challenging as some peptides in the saliva may be secreted 
by epithelial cells of salivary glands and oral microorgan-
isms, or may be produced by proteolysis or inflammatory 
factors associated with the body’s response to infection 
[60, 61], which might become confounding factors when 
searching for candidate diagnostic biomarkers of dental 
caries. Second, among the seven differentially expressed 
peptides, only four of them were identified successfully, 
while the other three had no matching results from LTQ-
Orbitrap-MS. We speculate these peptides might have 
varying stability when using different MS methods, and 
hopefully these peptides can be identified if we could 
introduce other precise methods of peptidomics with 
less impact on peptide stability in future studies. Third, 
the bio-informative identification of these identified pep-
tides were performed by searching human peptide and 
protein databases, indicating the authentic origination of 
these peptides may not fully match the identified sources 
present in the databases. There should also be some pos-
sibility that these peptides might be secreted by some 
microorganisms or other sources in saliva. This issue 
will not be fully resolved until the database is improved 
to become much more complete in the future, and we 
may have a look back on these peptides periodically as 
the database is ever-growing all the time. Fourth, as for 
histatin-1, due to the limitations of current methodology 
and dynamic transformation of histatin-1 in a variety of 
physiological, biochemical and metabolic processes, we 
were not able to detect the entire sequence of histatin-1 
by mass spectrometry, though we had confirmed levels of 
salivary histatin-1 are higher in children with s-ECC after 
treatment for 4  weeks compared with before treatment 
by western blotting. In the future, with the development 
of research technologies and improvement of peptid-
omic methodology, we are looking forward to perform-
ing more in-depth studies on the intrinsic mechanisms 
between histatin-1 and the occurrence and development 
of dental caries. Last but not the least, the number of sam-
ples analysed was not quite enough, which may limit the 
validity of the results. Further studies in larger patient 
cohorts with blinded samples are required to confirm the 
usefulness of these diagnosis-oriented peptides, together 
with the function and structures of these novel candidate 
biomarkers. This will facilitate saliva proteomic profiling 
of s-ECC at the molecular level and yield a better under-
standing of s-ECC and its prevention.
Conclusions
In summary, these results indicated that proteomics 
approaches can help discovery of new candidate bio-
markers and identification of s-ECC-related proteins. 
The combination of 4 peptides here (experimental m/z 
values: 1723.7, 1851.4, 2331.0, and 2995.7 Da) may be a 
diagnostic indicator of the status of s-ECC. Besides, 2 dif-
ferentially expressed peptides (experimental m/z values: 
1723.7 and 1886.5), which might be probably homog-
enous, were predicted to originate from histatin-1, and 
histatin-1 was also identified as one candidate biomarker 
at protein level. In the future, caries risk of children is 
hopeful to be assessed by testing the specific peptides in 
saliva, which can be useful for drawing up individualised 
preventive strategies.
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